Clinical Trial: Non-interventional Study of Ziprasidone in the Treatment of Bipolar and Schizoaffective Disorders.
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: Treatment Of Manic Or Mixed Episodes Of Up To Moderate Severity In Patients With Bipolar Disorder And Schizoaffective Disorder
Brief Summary: Assessment of ziprasidone safety and efficacy in the treatment of bipolar and schizoaffective disorders.
Detailed Summary: Method: Consecutive patient sampling. Patients were included in the study in consecutive manner if they fulfilled the inclusion criteria and any of the exclusion criteria were not present.
Sponsor: Pfizer
Current Primary Outcome:
- Clinical global impression [ Time Frame: 3 months ]
- Recording of extrapyramidal symptoms [ Time Frame: 3 months ]
- Changes in manic symptoms over course of treatment [ Time Frame: 3 months ]
Original Primary Outcome:
Current Secondary Outcome:
- Severity of disease [ Time Frame: 3 months ]
- Adverse Events [ Time Frame: 3 months ]
Original Secondary Outcome:
Information By: Pfizer
Dates:
Date Received: March 29, 2007
Date Started: April 2007
Date Completion:
Last Updated: June 30, 2015
Last Verified: June 2015
